As of 2026-09-19, the Relative Valuation of Abivax SA (ABVX.PA) is (26.01) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 91.00 EUR, the upside of Abivax SA based on Relative Valuation is -128.6%.
The range of the Relative Valuation is (22.21) - (27.94) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 7.1x | 6.3x |
| Forward P/E multiples | 4.4x - 6.3x | 5.5x |
| Fair Price | (22.21) - (27.94) | (26.01) |
| Upside | -124.4% - -130.7% | -128.6% |
| Date | P/E |
| 2026-09-18 | -20.65 |
| 2026-09-17 | -21.26 |
| 2026-09-16 | -20.52 |
| 2026-09-15 | -21.29 |
| 2026-09-14 | -22.61 |
| 2026-09-11 | -22.98 |
| 2026-09-10 | -22.76 |
| 2026-09-09 | -22.96 |
| 2026-09-08 | -22.91 |
| 2026-09-07 | -22.22 |
| 2026-09-04 | -22.14 |
| 2026-09-03 | -22.49 |
| 2026-09-02 | -21.93 |
| 2026-09-01 | -22.34 |
| 2026-08-31 | -22.13 |
| 2026-08-28 | -22.10 |
| 2026-08-27 | -22.68 |
| 2026-08-26 | -22.78 |
| 2026-08-25 | -23.21 |
| 2026-08-24 | -22.26 |
| 2026-08-21 | -23.10 |
| 2026-08-20 | -22.73 |
| 2026-08-19 | -23.44 |
| 2026-08-18 | -23.35 |
| 2026-08-17 | -24.03 |
| 2026-08-14 | -23.30 |
| 2026-08-13 | -24.19 |
| 2026-08-12 | -24.80 |
| 2026-08-11 | -24.96 |
| 2026-08-10 | -25.21 |
| 2026-08-07 | -25.89 |
| 2026-08-06 | -25.00 |
| 2026-08-05 | -24.75 |
| 2026-08-04 | -24.66 |
| 2026-08-03 | -24.34 |
| 2026-07-31 | -24.12 |
| 2026-07-30 | -24.62 |
| 2026-07-29 | -24.59 |
| 2026-07-28 | -24.68 |
| 2026-07-27 | -25.68 |
| 2026-07-24 | -25.59 |
| 2026-07-23 | -25.98 |
| 2026-07-22 | -26.18 |
| 2026-07-21 | -26.66 |
| 2026-07-20 | -26.79 |
| 2026-07-17 | -27.04 |
| 2026-07-16 | -27.07 |
| 2026-07-15 | -27.18 |
| 2026-07-14 | -26.93 |
| 2026-07-13 | -27.25 |